Aporte a la rutina de la trinchera asistencial donde los conocimientos se funden con las demandas de los pacientes, sus necesidades y las esperanzas de permanecer en la gracia de la SALUD.
sábado, 2 de enero de 2010
Subjective versus objective risk in genetic counse... [J Exp Clin Cancer Res. 2009] - PubMed result
J Exp Clin Cancer Res. 2009 Dec 21;28(1):157. [Epub ahead of print]
Subjective versus objective risk in genetic counseling for hereditary breast and/or ovarian cancers.
Caruso A, Vigna C, Marozzo B, Sega FM, Sperduti I, Cognetti F, Savarese A.
ABSTRACT: BACKGROUND: Despite the fact that genetic counseling in oncology provides information regarding objective risks, it can be found a contrast between the subjective and objective risk. The aims of this study were to evaluate the accuracy of the perceived risk compared to the objective risk estimated by the BRCApro computer model and to evaluate any associations between medical, demographic and psychological variables and the accuracy of risk perception. METHODS: 130 subjects were given medical-demographic file, Cancer and Genetic Risk Perception, Hospital Anxiety-Depression Scale. It was also computed an objective evaluation of the risk by the BRCApro model. RESULTS: The subjective risk was significantly higher than objective risk. The risk of tumour was overestimated by 56%, and the genetic risk by 67%. The subjects with less cancer affected relatives significantly overestimated their risk of being mutation carriers and made a more innacurate estimation than high risk subjects. CONCLUSION: The description of this sample shows: general overestimation of the risk, inaccurate perception compared to BRCApro calculation and a more accurate estimation in those subjects with more cancer affected relatives (high risk subjects). No correlation was found between the levels of perception of risk and anxiety and depression. Based on our findings, it is worth pursuing improved communication strategies about the actual cancer and genetic risk, especially for subjects at "intermediate and slightly increased risk" of developing an hereditary breast and/or ovarian cancer or of being mutation carrier.
PMID: 20025726 [PubMed - as supplied by publisher]
abrir aquí para acceder a éste y otros documentos NCBI NIH relacionados:
Subjective versus objective risk in genetic counse... [J Exp Clin Cancer Res. 2009] - PubMed result
No hay comentarios:
Publicar un comentario